Noteworthy, MYC gain or amplification is a feature of Group 3 subgroup gamma, while MYCN amplification is a characteristic of Group 4 subgroup alpha [8], thus pointing to a relationship between high EIF4EBP1 expression and MYC(N) amplification in MBs. Here, MYCN is linked to Mobius syndrome.